BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6546792)

  • 1. Vitamin D metabolism in osteogenesis imperfecta during calcitonin therapy.
    Nishi Y; Hyodo S; Yoshimitsu K; Sawano K; Yamaoka K; Seino Y; Usui T
    Pediatrics; 1984 Apr; 73(4):538-42. PubMed ID: 6546792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of porcine calcitonin therapy on vitamin D metabolism and clinical response in a patient with osteogenesis imperfecta.
    Nishi Y; Hyodo S; Ishida M; Yamaoka K; Seino Y; Usui T
    Acta Paediatr Scand; 1983 Jan; 72(1):149-52. PubMed ID: 6858681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
    Rosenberg E; Lang R; Boisseau V; Rojanasathit S; Avioli LV
    J Clin Endocrinol Metab; 1977 Feb; 44(2):346-55. PubMed ID: 557059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and related research in osteogenesis imperfecta.
    Sbyrakis S; Mengreli C; Côté GB; Morakis A
    Prog Clin Biol Res; 1982; 104():367-76. PubMed ID: 6298814
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of synthetic salmon calcitonin in osteogenesis imperfecta.
    Castells S; Lu C; Baker RK; Wallach S
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):1-14. PubMed ID: 4203843
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of porcine calcitonin in osteogenesis imperfecta tarda.
    Castells S; Inamdar S; Baker RK; Wallach S
    J Pediatr; 1972 May; 80(5):757-62. PubMed ID: 5062955
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D.
    Christiansen C; Christensen MS; McNair P; Nielsen B; Madsbad S
    Scand J Clin Lab Invest; 1982 Oct; 42(6):487-91. PubMed ID: 6760373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alkaline phosphatase and its isoenzyme activity of the blood in osteogenesis imperfecta before and during treatment with calcitonin].
    Bodziony J; Lukas W; Stanosek J; Ziarek S
    Padiatr Grenzgeb; 1988; 27(4):259-67. PubMed ID: 3174140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of osteogenesis imperfecta with calcitonin].
    Iester A; Marchesi A; Fásce L
    Minerva Pediatr; 1979 Mar; 31(6):443-500. PubMed ID: 470887
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
    Nunziata V; Giannattasio R; di Giovanni G; Lettera AM; Nunziata CA
    Clin Orthop Relat Res; 1993 Aug; (293):366-71. PubMed ID: 8339504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D, parathormone, and calcitonin profiles in persons with long-standing spinal cord injury.
    Vaziri ND; Pandian MR; Segal JL; Winer RL; Eltorai I; Brunnemann S
    Arch Phys Med Rehabil; 1994 Jul; 75(7):766-9. PubMed ID: 8024422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of vitamin D metabolites in maternal and umbilical cord blood of Libyan and Norwegian women.
    Markestad T; Elzouki A; Legnain M; Ulstein M; Aksnes L
    Hum Nutr Clin Nutr; 1984 Jan; 38(1):55-62. PubMed ID: 6607243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ultraviolet irradiation on plasma vitamin D and calcitonin levels in humans.
    Kokot F; Schmidt-Gayk H; Wiecek A; Mleczko Z; Bracel B
    Kidney Int Suppl; 1989 Nov; 27():S143-6. PubMed ID: 2636650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcitonin and phosphate metabolism. Analysis of active calcium and phosphorus in children treated with Calcitar].
    Vulović D; Stojanov Lj; Nedeljković V; Banicević M; Zamurović D
    Srp Arh Celok Lek; 1977 Nov; 105(11):967-74. PubMed ID: 617001
    [No Abstract]   [Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peri-osteocytic calcium fixation under calcitonin treatment. Microradiographic study using automatic analysis of images in 8 cases of osteogenesis imperfecta].
    Duriez J; Flautre B
    Nouv Presse Med; 1975 Jan; 04(2):97-100. PubMed ID: 1138231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum 24,25-dihydroxyvitamin D concentration during long-term anticonvulsant therapy in adult epileptics.
    Zerwekh JE; Homan R; Tindall R; Pak CY
    Ann Neurol; 1982 Aug; 12(2):184-6. PubMed ID: 6982022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.
    Zeitlin L; Rauch F; Travers R; Munns C; Glorieux FH
    Bone; 2006 Jan; 38(1):13-20. PubMed ID: 16162424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.